Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Trial for DaZhu Rhodiola Rosea Capsule in the Treatment of Coronary Artery Disease With Angina Pectoris
NCT03633890 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Trial for DaZhu Rhodiola Rosea Capsule in the Treatment of Coronary Artery Disease With Angina Pectoris
- Lead sponsor
- Beijing Anzhen Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- August 31, 2018
- Completion date
- February 28, 2019
- Enrollment
- 102 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.